[go: up one dir, main page]

NZ242875A - Tumour rejection antigens (tra's); tumour rejection antigen precursors (trap's); their uses and properties - Google Patents

Tumour rejection antigens (tra's); tumour rejection antigen precursors (trap's); their uses and properties

Info

Publication number
NZ242875A
NZ242875A NZ242875A NZ24287592A NZ242875A NZ 242875 A NZ242875 A NZ 242875A NZ 242875 A NZ242875 A NZ 242875A NZ 24287592 A NZ24287592 A NZ 24287592A NZ 242875 A NZ242875 A NZ 242875A
Authority
NZ
New Zealand
Prior art keywords
tumour rejection
tra
trap
properties
antigens
Prior art date
Application number
NZ242875A
Inventor
Thierry Boon
Der Bruggen Pierre Van
Den Eynde Benoit Van
Pel Aline Van
Plaen Etienne De
Christopher Lurquin
Patrick Chomez
Caita Traversari
Original Assignee
Ludwig Inst Cancer Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/807,043 external-priority patent/US5342774A/en
Application filed by Ludwig Inst Cancer Res filed Critical Ludwig Inst Cancer Res
Publication of NZ242875A publication Critical patent/NZ242875A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
NZ242875A 1991-05-23 1992-05-22 Tumour rejection antigens (tra's); tumour rejection antigen precursors (trap's); their uses and properties NZ242875A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US70570291A 1991-05-23 1991-05-23
US72883891A 1991-07-09 1991-07-09
US76436591A 1991-09-23 1991-09-23
US07/807,043 US5342774A (en) 1991-05-23 1991-12-12 Nucleotide sequence encoding the tumor rejection antigen precursor, MAGE-1

Publications (1)

Publication Number Publication Date
NZ242875A true NZ242875A (en) 1993-09-27

Family

ID=46202042

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ242875A NZ242875A (en) 1991-05-23 1992-05-22 Tumour rejection antigens (tra's); tumour rejection antigen precursors (trap's); their uses and properties

Country Status (4)

Country Link
KR (1) KR100261856B1 (en)
AU (1) AU664560B2 (en)
IE (1) IE921661A1 (en)
NZ (1) NZ242875A (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0624189A4 (en) * 1992-01-21 1995-05-17 Ludwig Inst Cancer Res METHOD FOR DETERMINING PRECURSORS OF CYTOLYTIC T-LYMPHOCYTES.

Also Published As

Publication number Publication date
KR100261856B1 (en) 2000-07-15
IE921661A1 (en) 1992-12-02
AU2158392A (en) 1992-12-30
AU664560B2 (en) 1995-11-23

Similar Documents

Publication Publication Date Title
NO944475L (en) Combined vaccines comprising Hepatite B surface antigen and other antigens
HUT66753A (en) Novel antibodies and methods for their use
FI962377A0 (en) Humanized antibodies and their use
ZA916646B (en) Novel isocarbostiryl compounds and anti-tumor use thereof
FR2663787B1 (en) ELECTROMAGNETIC WAVE DETECTOR.
IL85955A0 (en) Human tumor-associated antigen
ZA958229B (en) Composition containing tumor rejection antigen prcursors or tumor rejection antigens and an adjuvant and/or growth factor
EP0530216A4 (en) Administration of monoclonal antibodies against respiratory viruses
EP0469897A3 (en) Engineered antibodies
NZ242875A (en) Tumour rejection antigens (tra's); tumour rejection antigen precursors (trap's); their uses and properties
ZA924068B (en) Monoclonal antibodies and antigen for human melanoma
ZA923759B (en) Tumor rejection antigen precursors,tumor rejection antigens and uses thereof
IL95999A0 (en) Tumor-associated antigen
IT1241307B (en) DEVICE FOR THE TRANSPORT AND ALIGNMENT OF SHEETS
GB9014652D0 (en) Antigen
GB9021286D0 (en) Antigens and antibodies thereto their uses
EP0491351A3 (en) Chimeric antibodies and their use
AU8054491A (en) Monoclonal antibodies for identification and preparation of raf-1 oncoprotein
EP0445650A3 (en) Detection of anti-hiv antibodies
AU6964891A (en) Novel monoclonal antibody against human platelets
GB9118013D0 (en) Monoclonal antibodies and their use
CS512290A3 (en) Mouse hybridoma ifna1-118 producing monoclonal antibody binding the human interferon alpha 1
CS511090A3 (en) Mouse hybridoma ifna2-n10 producing monoclonal antibody binding the human interferon alpha 2
GB9004634D0 (en) An antibody and use thereof
GB9210944D0 (en) Monoclonal antibodies and their use

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
EXPY Patent expired